shares for debt Cool - signs of life
Feels like time to chip away . . .
Shell is pretty tight, s omaybe the pring is coiling?
EGF to settle $23,677 in director fees with shares
EGF Theramed Health Corp (2) (C:TMED)
Shares Issued 10,491,161
Last Close 7/23/2024 $0.10
Thursday July 25 2024 - News Release
Mr. Connor Yuen reports
EGF THERAMED ANNOUNCES SHARES FOR DEBT SETTLEMENT
EGF Theramed Health Corp. has entered into a shares for debt agreement with a former director of the company. Pursuant to this agreement, the company will issue 225,504 common shares at a deemed price of 10.5 cents per share to settle outstanding director fees totalling $23,677.92.
The issuance of shares to the former director represents payment for services and fees rendered during their tenure on the board of directors. This debt settlement will allow the company to preserve its cash resources while satisfying its obligations in a manner that is beneficial to both parties.
The shares issued in connection with this settlement will be subject to a four-month statutory hold period from the date of issuance, in accordance with applicable securities laws. This transaction remains subject to all necessary regulatory approvals, including acceptance by the Canadian Securities Exchange.
About EGF Theramed Health Corp.
EGF is a consumer technology company engaged in the provision of biomedical on-line services for monitoring and treating common health problems. The company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations as well as medical monitoring device technology. The company is working to collaborate with other companies for medical technology, equipment protocols and laboratory SOPs (standard operating procedures).